Climb Bio, Inc. (CLYM)
NASDAQ: CLYM · Real-Time Price · USD
10.91
+0.39 (3.71%)
May 21, 2026, 4:00 PM EDT - Market closed
Climb Bio Employees
As of December 31, 2025, Climb Bio had 29 total employees, including 28 full-time and 1 part-time employees. The number of employees increased by 11 or 61.11% compared to the previous year.
Employees
29
Change (1Y)
11
Growth (1Y)
61.11%
Revenue / Employee
n/a
Profits / Employee
-$1,820,414
Market Cap
521.15M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 29 | 11 | 61.11% | 28 | 1 |
| Dec 31, 2024 | 18 | 7 | 63.64% | 17 | 1 |
| Dec 31, 2023 | 11 | -32 | -74.42% | 9 | 2 |
| Dec 31, 2022 | 43 | 12 | 38.71% | 30 | 13 |
| Sep 30, 2022 | 43 | 15 | 53.57% | 43 | 0 |
| Jun 30, 2022 | 41 | 16 | 64.00% | 41 | 0 |
| Mar 31, 2022 | 37 | 15 | 68.18% | 37 | 0 |
| Dec 31, 2021 | 31 | 9 | 40.91% | 19 | 12 |
| Sep 30, 2021 | 28 | - | - | 28 | 0 |
| Jun 30, 2021 | 25 | - | - | 25 | 0 |
| Mar 31, 2021 | 22 | - | - | 13 | 9 |
Related Stocks
| Company Name | Employees |
|---|---|
| Ginkgo Bioworks Holdings | 485 |
| ProKidney | 231 |
| 4D Molecular Therapeutics | 196 |
| Ocugen | 116 |
| Upstream Bio | 75 |
| Prothena Corporation | 67 |
| Contineum Therapeutics | 51 |
| Shattuck Labs | 40 |
CLYM News
- 1 day ago - Climb Bio Teases Key Budoprutug, CLYM116 Readouts at BioConnect - MarketBeat
- 2 days ago - Climb Bio Transcript: H.C. Wainwright 4th Annual BioConnect Investor Conference - Transcripts
- 8 days ago - Climb Bio to Present New Budoprutug Clinical Data at European Hematology Association (EHA) 2026 Congress - GlobeNewsWire
- 10 days ago - Climb Bio to Present at Upcoming Investor Conferences - GlobeNewsWire
- 10 days ago - Climb Bio price target raised to $20 from $15 at H.C. Wainwright - TheFly
- 13 days ago - Climb Bio price target raised to $17 from $15 at Wedbush - TheFly
- 14 days ago - Climb Bio reports Q1 EPS (20c), consensus (31c) - TheFly
- 15 days ago - Climb Bio Reports First Quarter 2026 Financial Results and Provides Business Updates - GlobeNewsWire